BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang S, Zhang J, Lai X, Zhuang L, Wu J. Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients. Front Mol Biosci 2021;8:781307. [PMID: 35004851 DOI: 10.3389/fmolb.2021.781307] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Fu Y, Si A, Wei X, Lin X, Ma Y, Qiu H, Guo Z, Pan Y, Zhang Y, Kong X, Li S, Shi Y, Wu H. Combining a machine-learning derived 4-lncRNA signature with AFP and TNM stages in predicting early recurrence of hepatocellular carcinoma. BMC Genomics 2023;24:89. [PMID: 36849926 DOI: 10.1186/s12864-023-09194-8] [Reference Citation Analysis]
2 Lu J, Tan J, Yu X. A prognostic model based on tumor microenvironment-related lncRNAs predicts therapy response in pancreatic cancer. Funct Integr Genomics 2023;23:32. [PMID: 36625842 DOI: 10.1007/s10142-023-00964-x] [Reference Citation Analysis]
3 Dai X, Zeng M, Huang Z, Zhang J, Wei Z, Wang Z. A Novel Prognostic Chemokine-Related lncRNAs Signature Associated with Immune Landscape in Colon Adenocarcinoma. Disease Markers 2022;2022:1-38. [DOI: 10.1155/2022/2823042] [Reference Citation Analysis]
4 Liu Y, Yu M, Cheng X, Zhang X, Luo Q, Liao S, Chen Z, Zheng J, Long K, Wu X, Qu W, Gong M, Song Y. A novel LUAD prognosis prediction model based on immune checkpoint-related lncRNAs. Front Genet 2022;13:1016449. [DOI: 10.3389/fgene.2022.1016449] [Reference Citation Analysis]
5 Chen J, Li C, Lang Z, Zheng J, Yu S, Zhou Z. Identification and Validation of Genomic Subtypes and a Prognostic Model Based on Antigen-Presenting Cells and Tumor Microenvironment Infiltration Characteristics in Hepatocellular Carcinoma. Front Oncol 2022;12:887008. [PMID: 35720008 DOI: 10.3389/fonc.2022.887008] [Reference Citation Analysis]
6 Huang S, Li D, Zhuang L, Zhang J, Wu J. Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients. Front Med 2022;9:850343. [DOI: 10.3389/fmed.2022.850343] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Chen J, Lv B, Zhan Y, Zhu K, Zhang R, Chen B, Jin Y, Li Y, Zheng J, Lin C. Comprehensive Exploration of Tumor Microenvironment Modulation Based on the ESTIMATE Algorithm in Bladder Urothelial Carcinoma Microenvironment. Front Oncol 2022;12:724261. [DOI: 10.3389/fonc.2022.724261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]